Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1989 Jan;79(1):71–73. doi: 10.2105/ajph.79.1.71

Breast cancer incidence in young women by estrogen receptor status and race.

J L Stanford 1, R S Greenberg 1
PMCID: PMC1349474  PMID: 2909186

Abstract

A population-based study was utilized to calculate breast cancer incidence rates in White and Black women, ages 30 to 54, according to tumor estrogen receptor status. Both racial groups had higher incidence curves for estrogen receptor negative breast cancer between ages 30 and 49. There was an excess of receptor negative cancer in young Black women, an observation that may help explain the racial disparity in breast cancer survival.

Full text

PDF
71

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bain R. P., Greenberg R. S., Whitaker J. P. Racial differences in survival of women with breast cancer. J Chronic Dis. 1986;39(8):631–642. doi: 10.1016/0021-9681(86)90188-8. [DOI] [PubMed] [Google Scholar]
  2. Beverly L. N., Flanders W. D., Go R. C., Soong S. J. A comparison of estrogen and progesterone receptors in black and white breast cancer patients. Am J Public Health. 1987 Mar;77(3):351–353. doi: 10.2105/ajph.77.3.351. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Elwood J. M., Godolphin W. Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients. Br J Cancer. 1980 Nov;42(5):635–644. doi: 10.1038/bjc.1980.296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hawkins R. A., Roberts M. M., Forrest A. P. Oestrogen receptors and breast cancer: current status. Br J Surg. 1980 Mar;67(3):153–169. doi: 10.1002/bjs.1800670302. [DOI] [PubMed] [Google Scholar]
  5. Hildreth N. G., Kelsey J. L., Eisenfeld A. J., LiVolsi V. A., Holford T. R., Fischer D. B. Differences in breast cancer risk factors according to the estrogen receptor level of the tumor. J Natl Cancer Inst. 1983 Jun;70(6):1027–1031. [PubMed] [Google Scholar]
  6. Howell A., Barnes D. M., Harland R. N., Redford J., Bramwell V. H., Wilkinson M. J., Swindell R., Crowther D., Sellwood R. A. Steroid-hormone receptors and survival after first relapse in breast cancer. Lancet. 1984 Mar 17;1(8377):588–591. doi: 10.1016/s0140-6736(84)90995-4. [DOI] [PubMed] [Google Scholar]
  7. Hulka B. S., Chambless L. E., Wilkinson W. E., Deubner D. C., McCarty K. S., Sr, McCarty K. S., Jr Hormonal and personal effects on estrogen receptors in breast cancer. Am J Epidemiol. 1984 May;119(5):692–704. doi: 10.1093/oxfordjournals.aje.a113790. [DOI] [PubMed] [Google Scholar]
  8. Lesser M. L., Rosen P. P., Senie R. T., Duthie K., Menendez-Botet C., Schwartz M. K. Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology. Cancer. 1981 Jul 15;48(2):299–309. doi: 10.1002/1097-0142(19810715)48:2<299::aid-cncr2820480215>3.0.co;2-2. [DOI] [PubMed] [Google Scholar]
  9. McKeown-Eyssen G. E., Rogers-Melamed I., Clarke E. A. Estrogen receptor status of breast cancer in Ontario. CMAJ. 1985 Nov 15;133(10):997–1000. [PMC free article] [PubMed] [Google Scholar]
  10. McTiernan A., Thomas D. B., Johnson L. K., Roseman D. Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers. J Natl Cancer Inst. 1986 Oct;77(4):849–854. [PubMed] [Google Scholar]
  11. Mohla S., Sampson C. C., Khan T., Enterline J. P., Leffall L., Jr, White J. E. Estrogen and progesterone receptors in breast cancer in Black Americans: Correlation of receptor data with tumor differentiation. Cancer. 1982 Aug 1;50(3):552–559. doi: 10.1002/1097-0142(19820801)50:3<552::aid-cncr2820500328>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  12. Natarajan N., Nemoto T., Mettlin C., Murphy G. P. Race-related differences in breast cancer patients. Results of the 1982 national survey of breast cancer by the American College of Surgeons. Cancer. 1985 Oct 1;56(7):1704–1709. doi: 10.1002/1097-0142(19851001)56:7<1704::aid-cncr2820560740>3.0.co;2-l. [DOI] [PubMed] [Google Scholar]
  13. Ownby H. E., Frederick J., Russo J., Brooks S. C., Swanson G. M., Heppner G. H., Brennan M. J. Racial differences in breast cancer patients. J Natl Cancer Inst. 1985 Jul;75(1):55–60. [PubMed] [Google Scholar]
  14. Stanford J. L., Szklo M., Boring C. C., Brinton L. A., Diamond E. A., Greenberg R. S., Hoover R. N. A case-control study of breast cancer stratified by estrogen receptor status. Am J Epidemiol. 1987 Feb;125(2):184–194. doi: 10.1093/oxfordjournals.aje.a114519. [DOI] [PubMed] [Google Scholar]
  15. Stanford J. L., Szklo M., Brinton L. A. Estrogen receptors and breast cancer. Epidemiol Rev. 1986;8:42–59. doi: 10.1093/oxfordjournals.epirev.a036295. [DOI] [PubMed] [Google Scholar]
  16. Wittliff J. L. Steroid-hormone receptors in breast cancer. Cancer. 1984 Feb 1;53(3 Suppl):630–643. doi: 10.1002/1097-0142(19840201)53:3+<630::aid-cncr2820531308>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES